Login / Signup

Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression.

Ray Y WangPeter M HorwichVlad C SandulacheDavid J HernandezJoshua HornigEvan M GraboyesNelson E LiouJudith SkonerAngela D HaskinsViran RanasingheTerry A DayErich M SturgisAndrew T Huang
Published in: Head & neck (2022)
MVFTT of the head and neck appears to be safe in patients on chronic pharmacologic immunosuppression.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • patient reported